AAA State of Play1-877-826-2776
Home›Grant Finder›Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer's Disease (AD) and AD-related Dementias (ADRD) (UG3/UH3 Clinical Trial Required)

Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer's Disease (AD) and AD-related Dementias (ADRD) (UG3/UH3 Clinical Trial Required)

Sponsored by National Institutes of Health

Award
Varies — see funder site
Deadline
November 19, 2026
Geography
Open nationwide

Eligible organization types

  • Open to most organization types — confirm on funder site.

Project types funded

  • Project scope details on funder site.
Apply on funder site Find more grants

Need a quote for your grant application?

We’ll prepare a free, application-ready proposal — equipment, surfacing, shipping, and installation.

Get a free proposal 1-877-826-2776